Zimbabwe has rejected a significant US health deal worth 367 million US dollars (£272m) spanning five years over the United States' request for sensitive biological samples.
The decision came to light after a internal memorandum from December was disclosed, which showed Head of State Emmerson Mnangagwa felt the arrangement was "skewed".
A government representative has since clarified that the United States was seeking genetic material for research and commercial purposes while was unwilling to share the benefits from any future vaccines.
"We will now turn to the difficult and regrettable task of scaling back our support in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the US had provided more than $1.9bn in health funding to Zimbabwe during the past twenty years.
A physicians' group in Zimbabwe has appealed for continued dialogue to reach a agreement agreeable to all parties so the nation's critical HIV treatment initiative can proceed.
Broader Context
This rejection follows a comparable situation in Kenya, where a high court blocked a related deal with the US after concerns were raised about the safety of citizens' medical information.
After returning to office last year, US President Donald Trump has slashed foreign aid and closed the US Agency for International Development (USAID).
USAID had administered assistance for the US government, but Trump stated its spending was "inefficient" and his administration was pursuing government-to-government agreements to enhance transparency and responsibility.
According to statements, Sixteen African countries have so far agreed to similar agreements, representing over $18.3bn in committed funds.
Details of the Rejected Agreement
The funds for Zimbabwe was intended to gone towards "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this partnership could have provided extraordinary benefits for Zimbabwean communities, particularly the 1.2 million men, women and children presently on HIV treatment through US-supported programmes," the Ambassador added.
However, government spokesperson Nick Mangwana argued the proposed deal was "asymmetrical".
"The proposal required Zimbabwe to provide its biological resources and data indefinitely, without any corresponding guarantee of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might be developed from that shared data," Mangwana explained.
"Effectively, our nation would supply the raw materials for scientific discovery with no assurance that the end products would be accessible to our citizens if a future disease outbreak emerge."
National Interest and International Frameworks
Mangwana further pointed out that the US's withdrawal from the World Health Organization (WHO) and its pursuit of bilateral health agreements were disrupting frameworks previously established via the international organization.
Mangwana cited its Pathogen Access and Benefit Sharing system designed to manage future pandemics.
"This framework is designed to guarantee that when a nation provides its information, the benefits – such as vaccines and treatments – are shared equitably, not commercialised exclusively by those with the resources to create them."
These objections regarding the US deal "should not be misconstrued as opposition to America," Mangwana stressed.
"We encourage further discussions with our US partners on how future co-operation might be structured in a way that respects the independence and interests of each country."
Health Experts Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it understood the official position, but suggested that talks need to persist given that a large portion of the country's Aids initiatives depended on international support.
"In cases where technical issues arise, such as those involving data governance or agreement terms, these can often be addressed through technical clarification and mutually agreed protections," it added.
The halted deal emphasises the continuing challenges between accepting much-needed foreign assistance and safeguarding local interests in an ever more interconnected world.